Related Experiment Video
Updated: Feb 12, 2026

Induction and Validation of Cellular Senescence in Primary Human Cells
Published on: June 20, 2018
Induction, regulation and roles of neural adhesion molecule L1CAM in cellular senescence
Blanka Mrazkova1, Rastislav Dzijak1, Terezie Imrichova1
1Department of Genome Integrity, Institute of Molecular Genetics of the ASCR, Prague 14220, Czech Republic.
Abstract:
Aging involves tissue accumulation of senescent cells (SC) whose elimination through senolytic approaches may evoke organismal rejuvenation. SC also contribute to aging-associated pathologies including cancer, hence it is imperative to better identify and target SC. Here, we aimed to identify new cell-surface proteins differentially expressed on human SC. Besides previously reported proteins enriched on SC, we identified 78 proteins enriched and 73 proteins underrepresented in replicatively senescent BJ fibroblasts, including L1CAM, whose expression is normally restricted to the neural system and kidneys. L1CAM was: 1) induced in premature forms of cellular senescence triggered chemically and by gamma-radiation, but not in Ras-induced senescence; 2) induced upon inhibition of cyclin-dependent kinases by p16INK4a; 3) induced by TGFbeta and suppressed by RAS/MAPK(Erk) signaling (the latter explaining the lack of L1CAM induction in RAS-induced senescence); and 4) induced upon downregulation of growth-associated gene ANT2, growth in low-glucose medium or inhibition of the mevalonate pathway. These data indicate that L1CAM is controlled by a number of cell growth- and metabolism-related pathways during SC development. Functionally, SC with enhanced surface L1CAM showed increased adhesion to extracellular matrix and migrated faster. Our results provide mechanistic insights into senescence of human cells, with implications for future senolytic strategies.
Insights
Researchers identified L1CAM as a new cell-surface marker on senescent cells (SC). This discovery offers potential for developing novel senolytic therapies to target aging and associated diseases.
Area of Science:
- Cellular senescence
- Aging research
- Biomarker discovery
Background:
- Senescent cells (SC) accumulate with age and contribute to aging-associated diseases.
- Targeting SC with senolytic therapies may promote organismal rejuvenation.
- Identifying specific markers on SC is crucial for effective targeting.
Purpose of the Study:
- To identify novel cell-surface proteins differentially expressed on human senescent cells.
- To investigate the regulation and functional role of identified markers in senescence.
Main Methods:
- Comparative proteomic analysis of replicatively senescent human fibroblasts.
- Validation of protein expression changes in various senescence models (chemical, radiation, genetic).
- Investigation of signaling pathways (TGFbeta, RAS/MAPK) and metabolic influences on marker expression.
Main Results:
- Identified 78 enriched and 73 underrepresented proteins on senescent cells.
- Discovered L1CAM (normally restricted to neural system and kidneys) is induced in specific senescence types.
- L1CAM induction is linked to p16INK4a, TGFbeta signaling, and metabolic pathways, but not Ras-induced senescence.
- Senescent cells with increased L1CAM expression exhibit enhanced adhesion and migration.
Conclusions:
- L1CAM is a novel, dynamically regulated marker associated with cellular senescence.
- Senescence development involves intricate regulation by cell growth, metabolism, and signaling pathways.
- Findings provide mechanistic insights into senescence and potential targets for future senolytic strategies.
More Related Videos
Related Concept Videos
Neural Regulation
Negative Regulator Molecules
Positive Regulator Molecules
Positive Regulator Molecules
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved...

